Viral polymerase inhibitors
US7223785B2 · kind B2 · utility
22Cited by
4References
66Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2004 |
| Grant date | May 29, 2007 |
| Priority date | — |
| Expiry date | Dec 1, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I:wherein wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.